Heartflow Email Format
Medical Equipment Manufacturing
・
501-1,000 employees
・
San Francisco, CA, USA
Heartflow is a medical technology company that develops AI-driven precision heart analysis platforms for non-invasive coronary artery disease diagnosis and management worldwide.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
firstinitiallast@heartflow.com
Company Overview
Industry
Medical Equipment Manufacturing
Founded
2007
Headquarters
San Francisco, CA, USA
Revenue
$100M-$250M
FUNDING Stage
Public
Website
Key Executives
John Farquhar (President and CEO), Vikram Verghese (Chief Financial Officer), Justin Cambra (Chief Technology Officer)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Heartflow?
Heartflow uses the firstinitiallast format, so Jane Smith would be jsmith@heartflow.com.
What products does Heartflow offer on its Heartflow One platform?
The Heartflow One platform includes FFRCT Analysis, Plaque Analysis, Roadmap Analysis, and PCI Navigator. These AI-powered tools help clinicians diagnose and manage coronary artery disease using data from coronary CT scans across more than 1,800 institutions worldwide.
How can I find the right Heartflow contact for outreach or prospecting?
Heartflow follows a firstinitiallast email format at heartflow.com, so once you have a name you can build the address directly. Tools like Clay can help you verify and enrich Heartflow contacts, including identifying the right person by role or territory before reaching out.
Who is the CEO of Heartflow?
John Farquhar serves as President and CEO of Heartflow. Other members of the executive team include Vikram Verghese as Chief Financial Officer and Justin Cambra as Chief Technology Officer.
Which geographic markets does Heartflow currently serve with its AI cardiology tools?
Heartflow is commercially available in the United States, the European Union, the United Kingdom, Japan, and Canada, among other select regions. Its FFRCT Analysis alone covers 99.5% of U.S. insured lives and has been used to evaluate more than 650,000 patients globally.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating